palmidrol has been researched along with mocetinostat in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 4 (44.44) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| D'Argenio, G; Di Marzo, V; Gianfrani, C; Grandone, I; Mazzarella, G; Nigam, S; Petrosino, S; Scaglione, G; Sorrentini, I; Valenti, M | 1 |
| Bruschetta, G; Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Impellizzeri, D; Siracusa, R | 1 |
| Battista, G; Borrelli, F; Capasso, R; Coppola, D; Di Marzo, V; Izzo, AA; Orlando, P; Pagano, E; Petrosino, S; Romano, B | 1 |
| Alhouayek, M; Bottemanne, P; Cani, PD; Lambert, DM; Makriyannis, A; Muccioli, GG; Subramanian, KV | 1 |
| Cordaro, M; Crupi, R; Cuzzocrea, S; Esposito, E; Gugliandolo, E; Impellizzeri, D; Siracusa, R | 1 |
| Ardizzone, A; Casili, G; Cuzzocrea, S; Esposito, E; Fusco, R; Impellizzeri, D; Lanza, M | 1 |
| Allarà, M; De Petrocellis, L; Di Marzo, V; Izzo, AA; Manzo, E; Pagano, E; Petrosino, S; Schiano Moriello, A; Tinto, F; Verde, R | 1 |
| Cordaro, M; Crupi, R; Cuzzocrea, S; D'Amico, R; Di Paola, R; Fusco, R; Genovese, T; Gugliandolo, E; Impellizzeri, D; Peritore, AF; Siracusa, R | 1 |
9 other study(ies) available for palmidrol and mocetinostat
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Overactivity of the intestinal endocannabinoid system in celiac disease and in methotrexate-treated rats.
Topics: Adolescent; Adult; Amides; Animals; Arachidonic Acids; Atrophy; Cannabinoid Receptor Modulators; Case-Control Studies; Celiac Disease; Child; Diet, Protein-Restricted; Disease Models, Animal; Duodenum; Endocannabinoids; Ethanolamines; Female; Glycerides; Humans; Jejunum; Male; Methotrexate; Middle Aged; Palmitic Acids; Peroxidase; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Time Factors; Up-Regulation | 2007 |
Micronized/ultramicronized palmitoylethanolamide displays superior oral efficacy compared to nonmicronized palmitoylethanolamide in a rat model of inflammatory pain.
Topics: Administration, Oral; Amides; Analgesics; Animals; Carrageenan; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Disease Models, Animal; Edema; Ethanolamines; Hyperalgesia; Inflammation; Male; Microscopy, Electron, Scanning; Pain; Palmitic Acids; Peroxidase; Rats; Rats, Sprague-Dawley | 2014 |
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent.
Topics: Administration, Oral; Amides; Animals; Anti-Inflammatory Agents; Benzenesulfonates; Capsaicin; Colitis; Colon; Disease Models, Animal; Endocannabinoids; Ethanolamines; Intestinal Absorption; Male; Mice, Inbred ICR; Oleic Acids; Palmitic Acids; Peroxidase; PPAR alpha; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Cannabinoid; RNA, Messenger; TRPV Cation Channels | 2015 |
N-Acylethanolamine-hydrolyzing acid amidase inhibition increases colon N-palmitoylethanolamine levels and counteracts murine colitis.
Topics: Amides; Amidohydrolases; Animals; Anti-Inflammatory Agents; Arachidonic Acids; Chromatography, High Pressure Liquid; Colitis; Colon; Cytokines; Disease Models, Animal; Endocannabinoids; Enzyme-Linked Immunosorbent Assay; Ethanolamines; Gene Expression Regulation; Glycerides; Inflammation; Inflammatory Bowel Diseases; Male; Mice; Mice, Inbred C57BL; Neutrophils; Palmitic Acids; Peroxidase; Piperidines; Pyridines; Taurine | 2015 |
Adelmidrol, a Palmitoylethanolamide Analogue, as a New Pharmacological Treatment for the Management of Inflammatory Bowel Disease.
Topics: Amides; Animals; Anti-Inflammatory Agents; Apoptosis; Body Weight; Colitis; Cyclooxygenase 2; Cytokines; Dicarboxylic Acids; Dinitrofluorobenzene; Ethanolamines; Extracellular Signal-Regulated MAP Kinases; Inflammatory Bowel Diseases; Intercellular Adhesion Molecule-1; Lipid Peroxidation; Male; Mice; NF-kappa B; P-Selectin; Palmitic Acids; Peroxidase; Phosphorylation; PPAR alpha; PPAR gamma; Receptor, Cannabinoid, CB2; Signal Transduction; Tyrosine | 2016 |
Effect of Ultra-Micronized-Palmitoylethanolamide and Acetyl-l-Carnitine on Experimental Model of Inflammatory Pain.
Topics: Acetylcarnitine; Amides; Animals; Carrageenan; Cell Count; Cyclooxygenase 2; Disease Models, Animal; Edema; Ethanolamines; Hyperalgesia; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-1beta; Male; Mast Cells; Nitric Oxide Synthase Type II; Pain; Palmitic Acids; Peroxidase; Rats, Sprague-Dawley; Time Factors; Tumor Necrosis Factor-alpha | 2021 |
A Glucuronic Acid-Palmitoylethanolamide Conjugate (GLUPEA) Is an Innovative Drug Delivery System and a Potential Bioregulator.
Topics: Amides; Animals; Arachidonic Acids; Calcium; Chemokine CCL8; Colitis; Colon; Dinitrofluorobenzene; Drug Delivery Systems; Endocannabinoids; Ethanolamines; Glucuronic Acid; Glycerides; HaCaT Cells; HEK293 Cells; Humans; Ion Channel Gating; Keratinocytes; Male; Mice, Inbred ICR; Models, Biological; Palmitic Acids; Peroxidase; Poly I-C; TRPV Cation Channels | 2021 |
Management of Acute Lung Injury: Palmitoylethanolamide as a New Approach.
Topics: Acute Lung Injury; Amides; Animals; Cytokines; Ethanolamines; Immunohistochemistry; Inflammation; Interleukin-18; Interleukin-1beta; Interleukin-6; JNK Mitogen-Activated Protein Kinases; Lipopolysaccharides; Macrophages; Male; MAP Kinase Signaling System; Mast Cells; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neutrophils; NF-kappa B; NF-KappaB Inhibitor alpha; p38 Mitogen-Activated Protein Kinases; Palmitic Acids; Peroxidase; Tumor Necrosis Factor-alpha | 2021 |